Azithromycin versus Doxycycline in Pneumonia

Overview

About this study

The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

All adult patients (>18 years old) admitted with CAP within 12 hours.

Exclusion Criteria:

High suspicion for Legionella pneumonia
Allergy or contraindication to the use of either azithromycin or doxycycline (usual clinical practice)
Pregnant women

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 07/15/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Yewande Odeyemi, M.B.B.S.	Open for enrollment	Contact information: Yewande Odeyemi M.B.B.S. odeyemi.yewande@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Yewande Odeyemi, M.B.B.S.

Open for enrollment

Contact information:

Yewande Odeyemi M.B.B.S.

odeyemi.yewande@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials